Search Results for: food+intolerance/malabsorption

ANIL1986’S PERSONAL STORY

I am 29, Male, facing IBS, GERD from childhood.From past 2 years, i am 100% focused to surmount this problem.Few things that i am following and helped me reduce the suffering by 90%:1-maintain dairy and eleminate all the trigger points food, exercises.2-eat 5 times a day3-have vitamin supplements like B complex and Vitamin D, since […]

Read More »

Written Presentation to FDA September 12, 2017

On September 12, 2017, Ceciel Rooker presented the following research information to the US Food and Drug Administration (FDA) concerning the burdens and needs of gastroparesis patients: On behalf of the International Foundation for Functional Gastrointestinal Disorders (IFFGD), we appreciate the opportunity provided by the FDA to hear the patient perspective at the Patient-Focused Drug […]

Read More »

Written Comments to FDA October 17, 2018

The following written comments were submitted by IFFGD president, Ceciel T. Rooker, to the US Food and Drug Administration (FDA) in connection with a October 17, 2018 joint meeting of the FDA Gastrointestinal Drugs Advisory Committee to discuss approval of prucalopride: The International Foundation for Gastrointestinal Disorders (IFFGD) commends the FDA on its commitment to […]

Read More »

Testimony to FDA September 12, 2012

IFFGD Vice-President, William Norton, submitted the following written public testimony to the FDA in connection with an October 16, 2012 meeting of the Gastrointestinal Drugs Advisory Committee to consider the new drug application (NDA) 203441 by NPS Pharmaceuticals for the drug with the proposed trade name GATTEX® (teduglutide) for the treatment of adult patients with […]

Read More »

Testimony to FDA December 13, 2011

IFFGD Vice-President, William Norton, submitted the following written public testimony to the FDA in connection with a January 11, 2012 meeting of the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee to consider the premarket approval of the LINX Reflux Management System for the treatment of gastroesophageal reflux disease (GERD): On behalf […]

Read More »

Comments to FDA November 9, 2000

IFFGD sent the following written comments to the FDA in connection with a November 9, 2000 meeting of the Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee to discuss Lotronex: Recent attention has focused on the new drug, Lotronex, for the treatment of Irritable Bowel Syndrome (IBS) symptoms in women who suffer from IBS-associated […]

Read More »

Written Comments to FDA October 18, 2018

  The following written comments were submitted by IFFGD president, Ceciel T. Rooker, to the US Food and Drug Administration (FDA) in connection with a October 18, 2018 joint meeting of the FDA Gastrointestinal Drugs Advisory Committee and Risk Management Advisory Committee to discuss the reintroduction of Zelnorm: The International Foundation for Gastrointestinal Disorders (IFFGD) […]

Read More »

Cynthia’s Personal Story

Cynthia’s Personal Story: “I have been living with IBS for over 10 years” I am 28 years old and I have been living with IBS for over 10 years. It has not been easy and finding a good diet is the one main thing I struggle with because I love food. Over the past year […]

Read More at AboutIBS.org

Rosie’s Personal Story

Rosie’s Personal Story: Digestive Issues I’ve had digestion issues for a few years now. I am 72 years old. Most of my problem is bloating, looking pregnant. I was put on a low FODMAP diet and I also am lactose intolerant. What to eat? It’s been very difficult lately and if I want to go […]

Read More at AboutIBS.org

Dr. Dan Dumitrascu – IFFGD Research Award Winners: Where Are They Now?

2003 IFFGD Research Award Recipient Dan Dumitrascu, MD, PhD This episode is hosted by IFFGD’s Hayley McCorkle and features our 2003 Research Award Winner Dr. Dan Dumitrascu. Dr. Dumitrascu is a Food Professor at the Iuliu Hatieganu Medical University in Western Romania. He teaches gastroenterology, telemedicine, and psychosomatic medicine. Dr. Dumitrascu’s main interests are in […]

Read More »

Dr. Emeran Mayer – IFFGD Research Award Winners: Where Are They Now?

2009 IFFGD Research Award Recipient Emeran Mayer, MD Dr. Emeran Mayer, IFFGD’s 2009 Research Award Winner for Senior Investigator in Basic Science, explains his journey through research and provides us with great insight on topics like mind-brain-body interactions, the neurobiology of chronic functional pain syndromes, interoceptive mechanisms in food intake and gut inflammation, and advanced […]

Read More »

Overview of FODMAP Diet

Watch as Dr. Prashant Singh answers the question, “What do the letters of the FODMAP diet represent and what foods fall into each category?” Dr. Prashant Singh is an Assistant Professor of Medicine at the University of Michigan. He is not only one of IFFGD’s Junior Academicians but was also the winner of IFFGD’s 2024 […]

Read More »
Skip to content